Media Contact:
Julie Nettifee Osborne, College of Veterinary Medicine,
919/513-6812
Aug. 10, 2007
FOR IMMEDIATE RELEASE
At North Carolina State University’s College of Veterinary Medicine the “dog days of summer” have definitely begun. The college is recruiting dogs and cats for veterinary clinical studies with the aims of improving the quality of life for the pets undergoing treatment and providing valuable information that may enhance the lives of many other pets.
Diseases such as canine epilepsy, canine oral melanoma, and canine and feline lymphoma are among some of the more than 12 diseases now being studied in clinical trials at NC State’s Veterinary Teaching Hospital.
Veterinary neurologist Dr. Karen Munana is directing two studies: the Keppra study, which may offer treatment options for dogs with epilepsy, and the MDR-1 study, which is examining the genetic link between dogs with seizures and response to anticonvulsant medication in collies, shelties and Australian shepherds.
Dr. Laurel Williams is directing two lymphoma studies: one which monitors cardiac changes in dogs being treated for lymphoma, and one involving the use of a novel treatment protocol for cats with lymphoma.
Dr. Paul Hess, a veterinary internist and a specialist in tumor immunology, is director of a trial for a vaccine against oral melanoma in dogs.
Another study currently recruiting cases is evaluating the impact of normal activity on dogs with heart murmurs. This study is under the direction of Dr. Bernie Hansen, a specialist in internal medicine and emergency and critical care medicine and a leader in the Integrated Pain Management service.
Incentives and reimbursement for participants are available for some of the studies listed above. For more information, contact the study coordinators listed below:
- 30 -
RSS Feeds